Effect of Short-term Chinese Tea-flavor Liquor Consumption
NCT ID: NCT01294995
Last Updated: 2011-02-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
45 participants
INTERVENTIONAL
2010-10-31
2010-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Forty-five volunteers(23 males, 22 females) were selected to participate a paralleled randomized trial drinking 30 mL two kinds of Chinese liquors: TFL and GML respectively with meal every day for 28 days. Serums of volunteers were collected for analyzing serum lipids, inflammation biomarkers and CVD risk factors.
TFL could significantly decrease systolic blood pressure of males, but increase diastolic blood pressure of females. TFL could also decreased blood lipid of volunteers, especially for females. Both liquor significantly decrease serum uric acid and glucose in males and females. The effect of the two liquors on inflammation biomarkers were complicated and needs further research work.
TFL may possess more beneficial effect on CVD risk factors than GML probably because of the special fermentation products of green tea with other grains.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Postprandial Effect of Chinese Tea Flavor Liquor on Selected CVD Risk Factors
NCT01264666
Effect of Black Tea on Vascular Function
NCT01945970
Flow Mediated Dilation in Response to Black Tea
NCT02273323
Effects of Black Tea Intake on Serum Lipids
NCT01882283
Effects of a Beverage Rich in Fruit Extracts on Risk Factors Associated With Cardiovascular Disease
NCT00795834
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tea-flavor Liquor, taken with meal
including 12 males and 11 females
Tea-flavor Liquor
30 mL of Tea-flavor Liquor(45% alcohol content)
Guizhou Meijiao Liquor, taken with meal
including 11 males and 11 females
Guizhou Meijiao Liquor
30 mL of Guizhou Meijiao Liquor (45% alcohol content)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tea-flavor Liquor
30 mL of Tea-flavor Liquor(45% alcohol content)
Guizhou Meijiao Liquor
30 mL of Guizhou Meijiao Liquor (45% alcohol content)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Smokers
23 Years
28 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Guizhou Meijiao Co., Ltd
UNKNOWN
Zhejiang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Food Science and Nutrition
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of food science and nutrition
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ST Chinese liquor study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.